
---
title: '中关村：氨酚曲马多片一致性评价申报获受理'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=3594'
author: 证券时报网
comments: false
date: Thu, 24 Mar 2022 18:09:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=3594'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ000931" style="color: #2f67d1;text-decoration: none;" code="000931" target="_blank">中关村</a>(000931)3月24日晚间公告，全资子公司北京<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ000931" style="color: #2f67d1;text-decoration: none;" code="000931" target="_blank">中关村</a>四环医药开发有限责任公司之控股子公司多多药业收到国家药监局下发的氨酚曲马多片一致性评价《受理通知书》。</p>

                  
</div>
            